Electrical remodeling in atrial fibrillation: Time course and mechanisms

Circulation

Volumn 94, Issue 11, 1996, Pages 2968-2974

  Goette, Andreas ^a   Honeycutt, Clegg ^a   Langberg, Jonathan J ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

atrium; calcium; electrophysiology; fibrillation

Indexed keywords

GLIBENCLAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOVERSION; CONTROLLED STUDY; DOG; HEART ATRIUM FIBRILLATION; HEART VENTRICLE REMODELING; HYPERCALCEMIA; MITOCHONDRION SWELLING; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REFRACTORY PERIOD; TACHYCARDIA;

EID: 0029848995     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.11.2968     Document Type: Article

References (35)

1. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet. 1993;2:1317-1322.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of atrial fibrillation: the Framingham Study. N Engl J Med. 1982;306:1018-1022.
3. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983;106:389-396.
4. Greer GS, Wilkinson WE, McCarthy EA, Pritchett ELC. Random and nonrandom behavior of symptomatic paroxysmal atrial fibrillation. Am J Cardiol. 1989;64:339-342.
5. Allessie M, Konings K, Wijffels M. Electrophysiological mechanism of atrial fibrillation. In: DiMarco JP, Prystowsky EN, eds. Atrial Arrhythmias: State of the Art. Armonk, NY: Futura Publishing Co; 1995:155-161.
6. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frve RL. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med. 1987;317:669-674.
7. Suttorp MJ, Kingma HJ, Jessurun ER, Lie-A-Huen L, van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rythm. J Am Coll Cardiol. 1990;16:1722-1727.
8. Gold RL, Haffajee CI, Charos G, Sloan K, Baker S, Alpert JS. Amiodarone for refractory atrial fibrillation. Am J Cardiol. 1986;57:124-127.
9. Waris E, Kreus K, Salokannel J. Factors influencing persistence of sinus rhythm after DC shock treatment of atrial fibrillation. Acta Med Scand. 1971;189:161-166.
10. Crijns HJGM, Van Gelder IC, Van Gilst WH, Hillege H, Gosselink M, Lie KI. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol. 1991;68:335-341.
11. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 91;5:1588-1595.
12. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
13. Sideris DA, Toumanidis ST, Tselepatiotis E, Kostopoulos K, Stringli T, Kitsiou T, Moulopoulos SD. Atrial pressure and experimental atrial fibrillation. PACE. 1995;18:1679-1685.
14. Ravelli F, Alessie MA. Atrial stretch decreases refractoriness and induces atrial fibrillation in the isolated rabbit heart. Circulation. 1995;92(suppl I):I-754. Abstract.
15. Leistad E, Verburg E, Christensen G. Cytosolic calcium overload, not atrial ischemia, accounts for post-fibrillation atrial dysfunction. Circulation. 1994;90(suppl I):I-492. Abstract.
16. Jose AD, Taylor RR. Automatic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest. 1989;48:2019-2031.
17. + loss, reduction in repolarization time, and tissue ATP levels during myocardial hypoxia and ischemia. Circ Res. 1993;72:560-570.
18. Cascio W, Johnson TA, Getes LS. Electrophysiologic changes in ischemic ventricular myocardium: influence of ionic, metabolic, and energic changes. J Clin Electrophys. 1995.
19. + loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ Res. 1991;69:623-637.
20. Tieleman RG, de Langen CDJ, van der Woude HJ, Grandjean JG, Bel KJ, Wijffels MCEF, Allessie MA, Crijns HJGM. Reduction of electrical remodeling of the atrium by verapamil. Circulation. 1995;92(suppl I):I-754. Abstract.
21. Koretsuni Y, Marban E, Cell calcium in the pathophysiology of ventricular fibrillation and the pathogenesis of postarrhythmic contractile dysfunction. Circulation. 1989;80:369-379.
22. Zaugg CE, Wu ST, Kojima S, Wikman-Coffelt, Pannley WW, Buser PT. Role of intracellular calcium in the antiarrhythmic effect of pro- cainamide during ventricular fibrillation in rat hearts. Am Heart J. 1995;130:351-358.
23. i, transients during ventricular fibrillation and quinidine treatment in perfused rat hearts. Am J Physiol. 1994;266:H1473-H1484.
24. Stefenelli T, Wu ST, Parmley WW, Wikman-Coffelt J. Effects of propafenone on pacing-induced ventricular fibrillation and intracellular calcium in rat hearts. Eur Heart J. 1992;13;1556-1561.
25. Engel AG, Franzini-Amstrong C. Myology. New York, NY: Raven Press; 1992:641-642.
26. Hagler HK, Sherwin L, Buja LM. Effect of different methods of tissue preparation on mitochondrial inclusions of ischemic and infarcted canine myocardium: transmission and analytical electron microscopic study. Lab Invest. 1979;40:529-537.
27. Lee KS, Marban E, Tsien RW. Inactivation of calcium channels in mammalian heart cells: joint dependence on membrane potential and intracellular calcium. J Physiol. 1985;364:395-411.
28. + current in isolated membrane patches of guinea pig ventricular myocytes. Circ Res. 1994;74:96-104.
29. Shibata EF, Drury T, Refsum H, Aldrete V. Giles W. Contributions of a transient outward current to repolarisation in human atrium. Am J Physiol. 1989;257:H1773-H1781.
30. Escande D, Coulombe A, Faivre JF, Deroubaix E, Coraboeuf E. Two types of transient outward currents in adult human atrial cells. Am J Physiol. 1987;252:H142-H148.
31. Daoud EG, Niebauer M, Bogun F, Castellani M, Chan KK, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F. Atrial fibrillation induced shortening of atrial refractoriness in humans. Circulation. 1995;92(suppl I):I-404. Abstract.
32. Shenasa M, Kus T, Fromer M, LeBlanc RA, Dubuc M, Nadeau R. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol. 1988;62:403-407.
33. Singh BN, Nademanee K. Use of calcium antagonists for cardiac arrhythmias. Am J Cardiol. 1987;59:153B-162B.
34. Waxman HL, Meyerburg RJ, Appel R, Sung RJ. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter. Ann Intern Med. 1981;94:1-6.
35. Ochs HR, Anda L, Eichlbaum M, Greenblatt DJ. Diltiazem, verapamil and quinidine in patients with chronic atrial fibrillation. Clin Pharmacol. 1985;25:204-209.